Tech Strikes: Syndio hires managing director; ex-Adaptive CMO joins Freenome

Ritu Mohanka. (Syndio Photograph)

 Ritu Mohanka, vice chairman of technique & growth EMEA at Glint (a part of LinkedIn), is now the managing director and head of EMEA at Seattle startup Syndio.

Mohanka has prior expertise at Kenexa Inc. (which later turned IBM Smarter Workforce) and was named on the EMpower High 100 Ethnic Minority Senior Govt listing in 2021. She led the variety, inclusion, and belonging initiative at Glint to deal with discrimination in hiring practices.

Syndio supplies a software program resolution that makes use of knowledge science to advertise equitable workplaces by way of monitoring pay and different metrics. Syndio raised $50 million in September. The corporate is now increasing to the UK and EMEA market.

“Range, fairness, and honest pay are intertwined — and except you deal with root causes of inequities, it’s possible you’ll not find yourself higher off than initially,” Mohanka stated in an announcement.

Lance Baldo departed from Adaptive Biotechnologies, a Seattle-based biotech firm, and joined San Francisco-based Freenome as its chief medical officer.

Baldo has greater than 20 years of expertise in healthcare management. Previous to his place as chief medical officer at Adaptive, Baldo was the pinnacle of US medical affairs for Genentech and the overall supervisor for Roche Merchandise New Zealand’s affiliate.

Freenome is a biotechnology firm targeted on detecting early-stage most cancers in a person’s blood plasma by way of synthetic intelligence. The corporate landed $300 million in enterprise capital in a Sequence D spherical.

Supply hyperlink

Comments are closed.